ANI FITZGERALD: Open Payments
NPI 1366190647 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,392 in 139 payments from 15 companies in 2025. Trend: 2023 $579 · 2024 $1,389 · 2025 $2,392
Food & beverage: $2,392
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $407 |
| ABBVIE INC. | 19 | $276 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $265 |
| Janssen Pharmaceuticals, Inc | 5 | $242 |
| Axsome Therapeutics, Inc. | 10 | $211 |
| E.R. Squibb & Sons, L.L.C. | 18 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $188 |
| Teva Pharmaceuticals USA, Inc. | 12 | $180 |
| Lundbeck LLC | 10 | $141 |
| Vanda Pharmaceuticals Inc. | 4 | $111 |
Products named: REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, Auvelity, COBENFY, TRINTELLIX, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
